New Study Released on Fotona's NightLase® Anti-Snoring Laser Treatment

July 2022

Fotona's NightLase® anti-snoring laser treatment has been gaining worldwide recognition for it's safety and efficacy.

A newly published article by Dr. Valerie A. Picavet, et al. in the prestigious European Archives of Oto-Rhino-Laryngology presents the data from a recent study that assessed the safety and efficacy of the minimally invasive NightLase® therapy, comparing the results with a sham treatment.

The authors of the study concluded that:

"NightLase treatment significantly reduced snoring compared to sham treatment. Its efficacy is similar to that achieved with other more aggressive treatments.

Taking into account the minimal invasiveness of NightLase, this procedure seems to represent a valuable, low-risk treatment option for primary snoring/mild OSAS."


It should also be noted that the treatment was well tolerated by patients, with no local anaesthesia required.

The full text of the journal article, titled: Treatment of snoring using a non‑invasive Er:YAG laser with SMOOTH mode (NightLase): a randomized controlled trial, can be viewed on the publisher's website.

Related news

The 16th LA&HA Symposium – Exploring New Frontiers in Laser and Energy-Based Medicine

June 2026

The 16th Laser & Health Academy (LA&HA) Symposium welcomed more than 800 participants from around the world for another inspiring gathering dedicated to advancing knowledge, innovation, and collaboration in laser medicine.

Four New Studies Support the Use of Non-ablative Fotona SMOOTH® Technology for SUI

December 2025

Data all over the world continue to support the effectiveness of Fotona SMOOTH® for Stress Urinary Incontinence.

LA&HA Uzbekistan Training Centre Officially Announced in Tashkent

October 2025

A new LA&HA Uzbekistan Training Centre was officially unveiled on October 16th, 2025, during an opening event in Tashkent.